Eric Lefkofsky: Why Harnessing Data Can Change Treatment Mechanisms

Eric Lefkofsky is passionate about using big data to provide alternative solutions. For this reason, he has leverage data to assist in the diagnosis and treatment of cancer. Eric Lefkofsky emphasizes the importance of gathering molecular and clinical data in prognosis. Clinical data collection entails phenotypic information, outcome and therapeutic response while molecular data gives genomic information. Data on the patient, drug history and response and molecular response can help doctors and physicians analyze the risk of treatment, deduce answers for the differences in the response of patients and help in further research.

After experiencing his wife’s battle with breast cancer, Eric realized that data collection and digital technology was not being utilized fully in the healthcare sector. Surprisingly, a lot of data was generated on patient information and treatments but there was no mechanism that allowed the professionals to synchronize and use the data effectively.

The need to make sense of data led to the formation of Tempus, a company that specializes in precision medicine. Erick Lefkofsky is the Chief executive officer and co-founder of the company. The primary objective of Tempus is to revolutionize cancer care. As such, they have created an analytics software that enables outlines and evaluates the clinical and molecular information. The company has had to overcome challenges such as affordability and accessibility of the data at the initial stage. Plus, processing the physician notes that are the primary source of information about the patient’s condition, can be difficult to understand and follow. Nevertheless, the Tempus software allows optical character recognition and processing of natural language. Eric believes that the use of data enabled treatments will increase in future as technology advances. He is hopeful that improvements in genome sequencing will further cancer research and treatment.

Eric Lefkofsky is an alumnus of the University of Michigan. He volunteers on the board of directors of the Art Institute of Chicago and Lurie’s Children’s Memorial Hospital. He lectured at the Kellogg School of Management in Northwestern Univerity and the Depaul University Kellstadt Graduate School of Business. Currently, he is a professor at the Booth School of Business, University of Chicago.

Read More: lefkofskyfoundation.com/